| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 03/24/2005 | CA2536107A1 Substituted piperazines of azepines, oxazepines, and thiazepines |
| 03/24/2005 | CA2536052A1 Novel crystalline compounds |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/23/2005 | EP1515722A2 Ophthalmic compositions for treating ocular hypertension |
| 03/23/2005 | EP1381392A4 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CA2482113A1 Process for the purification of thiophenes |
| 03/22/2005 | US6870055 Heterocyclic amides such as 3-dimethylaminomethyl-6-methoxy-2 -methyl-4-phenyl-2H-isoquinoline-1-one, used as antiarrhythmic agents |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use |
| 03/17/2005 | WO2005023819A1 Thienopyrroles as antiviral agents |
| 03/17/2005 | WO2005023818A2 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | US20050059729 Substituted cyclic compounds |
| 03/17/2005 | US20050059726 For treating thrombosis and factor xa-related cardiovascular and neurodegenerative diseases; 6-Chloro-N-{(3S)-1-[3-fluoro-2'-(methylsulfonyl)-1,1'-biphenyl-4-yl]-2-oxopyrrolidin-3-yl}naphthalene-2-sulfonamide for example |
| 03/17/2005 | US20050059725 Treating schizophrenia or Parkinson's disease with thiolutin dioxide |
| 03/17/2005 | US20050059696 Process for the recovery of S -(+)-methyl- (2-chlorophenyl)- (6,7-dihydro- 4H-thieno [3,2-c] pyrid-5-yl) acetate hydrogen sulfate (clopidogrel bisulfate) from its (R) and mixture of (R) and (S)- isomers |
| 03/17/2005 | US20050059663 4-{3-[4-(6-Chlorobenzothiazol-2-yl)-1,4-diazepan-1-ylcarbonyl]benzyl}-1(2H)-phthalazinone; Cancer, BRCA deficient |
| 03/17/2005 | US20050059651 Lactam derivatives as antagonists for human 11cby receptors |
| 03/17/2005 | CA2572750A1 Heterobicyclic compounds as pharmaceutically active agents |
| 03/17/2005 | CA2537545A1 Thienopyrroles as antiviral agents |
| 03/16/2005 | EP1513846A1 Process of preparation of olanzapine form i |
| 03/16/2005 | EP1513845A1 A process for the preparation of olanzapine and an intermediate therefor |
| 03/16/2005 | EP1513828A1 New compounds useful for the treatment of obesity, type ii diabetes and cns disorders |
| 03/16/2005 | EP1513516A1 SUBSTITUTED 3-AMINO-THIENO(2,3-b) PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS ANDPROCESSES FOR PREPARING AND THEIR USES |
| 03/16/2005 | EP1399436B1 Oxytocin agonists |
| 03/16/2005 | EP1351962B1 Thienopyrimidine |
| 03/16/2005 | EP1226119B1 Tyrosine kinase inhibitors |
| 03/16/2005 | EP0869966B1 Prodrugs of thrombin inhibitors |
| 03/16/2005 | CN1596247A Lactam derivatives as antagonists for human 11CBY receptors |
| 03/15/2005 | US6867281 Organic light emitters |
| 03/15/2005 | US6866963 Cathode active material and lithium battery employing the same |
| 03/15/2005 | CA2334870C Polymorphic form of clopidogrel hydrogen sulphate |
| 03/15/2005 | CA2246595C Novel atropisomers of 2,3-disubstituted-(5,6)-heteroarylfused-pyrimidin-4-ones |
| 03/10/2005 | WO2005021554A1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | WO2005021553A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | WO2005021552A1 Pyrimidothiophene compounds |
| 03/10/2005 | WO2005020987A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity |
| 03/10/2005 | WO2005020986A1 Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity |
| 03/10/2005 | WO2005020897A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/10/2005 | WO2004098284A3 Pesticidal (dihalopropenyl)phenylalkyl substituted benzodioxolane and benzodioxole derivatives |
| 03/10/2005 | WO2004087673B1 Migrastatin analogs and uses thereof |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/10/2005 | US20050054696 Indole compounds and medicinal use thereof |
| 03/10/2005 | US20050054657 Induce immunology response; anticancer agents |
| 03/10/2005 | US20050054651 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 03/10/2005 | CA2536788A1 Naphthalene carboxamides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | CA2536321A1 Thienopyridine-phenylacet amides and their derivatives useful as new anti-angiogenic agents |
| 03/10/2005 | CA2535265A1 Compositions and methods for the treatment of disease associated with trp-p8 expression |
| 03/09/2005 | EP1480985B1 Salt of benzosulfonic acid containing clopidogrel and use thereof for the production of pharmaceutical formulations |
| 03/09/2005 | EP1057814B1 Tetrahydrobenzindole derivatives |
| 03/09/2005 | CN1192028C Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 03/08/2005 | US6864375 Thiophene derivatives; an electrooptic device such as a waveguide, switch, modulator, coupler, router, (tele)communications system, data transmission device, and a interferometric optical modulator or switch |
| 03/08/2005 | US6864333 Process for the preparation of ethylene polymers |
| 03/08/2005 | US6864253 Heterocyclic amines such as 1-(3,4-methylenedioxyphenyl)-2-(5 -(3,4-dimethoxyphenyl)pyrimidin-2-yl)- 2,3,4,9-tetrahydro-1H-beta-carboline, used as enzyme inhibitors for prophylaxix of sexual disorders |
| 03/03/2005 | WO2005020293A2 Highly conducting and transparent thin films formed from new fluorinated derivatives of 3,4-ethylenedioxythiophene |
| 03/03/2005 | WO2005019224A2 Novel antiinfective compounds |
| 03/03/2005 | WO2005019210A1 Polythiophene-based sensors |
| 03/03/2005 | WO2005019201A2 Process for the preparation of 4-amino-3-quinolinecarbonitriles |
| 03/03/2005 | WO2005019181A1 Migrastatin analog cell migration inhibitors |
| 03/03/2005 | WO2005018637A1 Heterocyclic amide derivatives which possess glycogen phosphorylase inhibitory activity |
| 03/03/2005 | WO2004106345A3 Heteroaryl-ethanolamine derivatives as antiviral agents |
| 03/03/2005 | WO2004101553B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |
| 03/03/2005 | WO2004029212A3 In vivo gene silencing by chemically modified and stable sirna |
| 03/03/2005 | US20050049415 Process for preparing enantiomerically pure alpha phenyl-alpha (6,7-dihydro-4h-thieno[3,2-c]pyridin-5-yl)-acetic acid derivatives |
| 03/03/2005 | US20050049406 Isotopically coded affinity markers 3 |
| 03/03/2005 | US20050049270 6H,11H-Indole-[3,2-C]-Isoquinoline-5-one derivatives; nuclear enzyme poly (ADP-ribose) synthetase inhibitors; inflammatory and/or reperfusion diseases |
| 03/03/2005 | US20050049262 Substituted 2,5-dioxopurines, 2H-1,2,3-triazolyl[4,5-d]pyrimidines, or 1,2,5-thadiazolyl[3,4-d]pyrimidines; antiproliferative, antiinflammatory, and antiarthritic agents; psoriasis, asthma, multiple sclerosis, inflammatory bowel disease, lupus, graft versus host disease |
| 03/03/2005 | US20050049245 Herpes viruses; such as N-(4-chlorobenzyl)-2-(((2-(2-furyl)-2-hydroxyethyl)(methyl)amino) methyl)-7-methyl-4-oxo-4,7-dihydrothieno[2,3-b]pyridine-5-carboxamide |
| 03/03/2005 | US20050049226 Preparation of (S)-clopidogrel and related compounds |
| 03/03/2005 | CA2535385A1 Process for the preparation of 4-amino-3-quinolinecarbonitriles |
| 03/02/2005 | EP1510535A1 Mono-, Oligo- and Polythieno(2,3-b)thiophenes |
| 03/02/2005 | EP1510516A1 Pyrazole compound and medicinal composition containing the same |
| 03/02/2005 | EP1509531A1 Methods for preparation of olanzapine polymorphic form i |
| 03/02/2005 | EP1509530A1 2-thia-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509528A2 1,3-diaza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 03/02/2005 | EP1509514A1 Anthelmintic and insecticidal thiophene derivatives |
| 03/02/2005 | EP1144416B1 Heterocyclically anellated indenochromene derivatives |
| 03/02/2005 | EP0948499B1 Heteroarylsulfonamide derivatives and pharmaceutical compositions containing them |
| 03/02/2005 | CN1589271A Fused heterocyclic succinimide compounds and analogs thereof as modulators of nuclear hormone receptor function |
| 03/01/2005 | US6861438 7-oxo-4,7-dihydro-thieno(3,2-b)pyridine-6-carboxylic acid benzylamide derivatives; herpes viricides |
| 02/24/2005 | WO2005016932A1 Pyranobenzothiophene derivatives to treat infection with hepatitis c virus |
| 02/24/2005 | WO2005016931A2 Crystallisation of solid forms of clopidogrel addition salts |
| 02/24/2005 | WO2005016919A1 Aminopyrones and their use as atm inhibitors |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | WO2005016255A2 Substituted tetrahydroquinolines, phenylacetic acids and benzoic acids as hepatocyte nuclear factor 4 (hnf-4 ) modulator compounds |
| 02/24/2005 | WO2005016000A1 Derivatives of cyclic quinone and uses thereof |
| 02/24/2005 | WO2004094400A3 Substituted benzopyrans as selective estrogen receptor-beta agonists |
| 02/24/2005 | WO2004087056A3 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 02/24/2005 | WO2004078712A3 Isoquinoline derivatives and methods of use thereof |
| 02/24/2005 | US20050043537 Amidation of cyanoacetic acid with an acid catalyst, condensation of the cyanoacetamide with aniline, an alcohol solvent, and a trialkylorthoformate, cyclization of the 3-amino-2-cyanoacrylamide; mild conditions; protein kinase inhibitors |
| 02/24/2005 | US20050043379 Leukotriene hydrolase inhibitors; antiinflammatory agents; antihistamines; chronic onstructive pulmonary disorders; atherosclerosis; multiple sclerosis; inflammatory bowel disorders; antiarthritic agents ;psoriasis |
| 02/24/2005 | US20050043378 LTA4H modulators |
| 02/24/2005 | US20050043347 N-94-94-amino-7-(3-(dimethylamino)-1-propynyl)thieno93,2-c)pyridin-3-yl)phenyl-N'-(3-methylphenyl)urea; controlling cell differentiation, cell proliferation or metabolism; anticancer agents; antidiabetic agents; antiinflammatory agents |
| 02/24/2005 | US20050042771 Identifying non-drug targets; use in drug design for improving knowledge of drug-target and drug-non-target interactions, so that drug adverse reactions can be reduced or eliminated in drugs such as troglitazone, rosiglitazone, pioglitazone, methotrexate, atorvastatin, celecoxib, rofecoxib, cerivastatin |
| 02/24/2005 | US20050042713 Characterising polypeptides |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |